{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-24-005773","form_type":"8-K","ticker":"CBDW","cik":"0001877461","company_name":"1606 CORP.","filed_at":"2024-09-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.079287+00:00","generated_at":"2026-05-31T04:22:19.521739+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"1606 Corp. signs LOI for strategic stake in AI drug-discovery firm Adnexus Biotechnologies","bullets":["Signed LOI to acquire a strategic stake in Adnexus Biotechnologies; no deal value disclosed.","Adnexus operates SUTRA AI platform for infectious/neurological disease drug discovery.","SUTRA platform includes data on 19 viruses, 8M molecules, and human microbiome samples.","Transaction subject to due diligence and standard conditions; no expected close date given.","Both CEOs expressed optimism about the partnership advancing AI-driven drug development."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-24-005773","json":"https://secwatch.observer/filing/0001477932-24-005773.json","markdown":"https://secwatch.observer/filing/0001477932-24-005773.md","text":"https://secwatch.observer/filing/0001477932-24-005773.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1877461/000147793224005773/0001477932-24-005773-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1877461/000147793224005773/cbdw_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:22:19.521739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}